Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Passage BIO, Inc. | 203,000 | reported | 15 Mar 2024 | tx 14+925,000−72,451 |
| Ventyx Biosciences, Inc. | 0 | reported | 04 Mar 2026 | tx 7+441,000−441,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Mar 2026 | OTHER | Ventyx Biosciences, Inc. | 6,000 | — | |
| 04 Mar 2026 | OTHER | Ventyx Biosciences, Inc. | 85,000 | — | deriv |
| 04 Mar 2026 | OTHER | Ventyx Biosciences, Inc. | 350,000 | — | deriv |
| 17 Nov 2025 | GRANT_AWARD | Ventyx Biosciences, Inc. | 3,000 | 1.03 USD | |
| 15 May 2025 | GRANT_AWARD | Ventyx Biosciences, Inc. | 3,000 | 1.03 USD | |
| 02 Jan 2025 | GRANT_AWARD | Ventyx Biosciences, Inc. | 85,000 | 0.00 USD | deriv |
| 12 Aug 2024 | GRANT_AWARD | Ventyx Biosciences, Inc. | 350,000 | 0.00 USD | deriv |
| 15 Mar 2024 | GRANT_AWARD | Passage BIO, Inc. | 203,000 | 0.00 USD | deriv |
| 13 Feb 2024 | SALE | Passage BIO, Inc. | 1,638 | 0.97 USD | |
| 10 Feb 2024 | EXERCISE | Passage BIO, Inc. | 5,000 | — | |
| 16 Aug 2021 | GRANT_AWARD | Passage BIO, Inc. | 130,000 | 0.00 USD | deriv |
| 10 Feb 2024 | EXERCISE | Passage BIO, Inc. | 5,000 | 0.00 USD | deriv |
| 10 Feb 2022 | GRANT_AWARD | Passage BIO, Inc. | 15,000 | 0.00 USD | deriv |
| 10 Feb 2022 | GRANT_AWARD | Passage BIO, Inc. | 25,000 | 0.00 USD | deriv |
| 31 Dec 2023 | EXERCISE | Passage BIO, Inc. | 50,000 | — | |
| 02 Jan 2024 | SALE | Passage BIO, Inc. | 15,813 | 0.91 USD | |
| 31 Dec 2023 | EXERCISE | Passage BIO, Inc. | 50,000 | 0.00 USD | deriv |
| 15 Mar 2023 | GRANT_AWARD | Passage BIO, Inc. | 175,000 | 0.00 USD | deriv |
| 10 Nov 2022 | GRANT_AWARD | Passage BIO, Inc. | 50,000 | 0.00 USD | deriv |
| 13 Jun 2022 | GRANT_AWARD | Passage BIO, Inc. | 136,000 | 0.00 USD | deriv |
| 18 Apr 2022 | GRANT_AWARD | Passage BIO, Inc. | 136,000 | 0.00 USD | deriv |